Fulgent Genetics, Inc. Quarterly Depreciation in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fulgent Genetics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2017 to Q3 2024.
  • Fulgent Genetics, Inc. Depreciation for the quarter ending September 30, 2024 was $3.8M, a 11.6% decline year-over-year.
  • Fulgent Genetics, Inc. Depreciation for the twelve months ending September 30, 2024 was $16.8M, a 18.8% decline year-over-year.
  • Fulgent Genetics, Inc. annual Depreciation for 2023 was $17.5M, a 31.4% decline from 2022.
  • Fulgent Genetics, Inc. annual Depreciation for 2022 was $25.5M, a 174% increase from 2021.
  • Fulgent Genetics, Inc. annual Depreciation for 2021 was $9.3M, a 210% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $16.8M $3.8M -$500K -11.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $17.3M $4M -$100K -2.44% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $17.4M $4.6M -$100K -2.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $17.5M $4.4M -$3.2M -42.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $20.7M $4.3M -$3.3M -43.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $24M $4.1M -$2.5M -37.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $26.5M $4.7M +$1M +27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $25.5M $7.6M +$5M +192% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $20.5M $7.6M +$5.1M +204% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $15.4M $6.6M +$4.3M +187% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $11.1M $3.7M +$1.8M +94.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $9.3M $2.6M +$1.44M +124% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $7.86M $2.5M +$1.78M +246% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $6.08M $2.3M +$1.75M +319% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $4.33M $1.9M +$1.33M +234% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $3M $1.16M +$609K +111% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $2.39M $722K +$219K +43.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.17M $549K +$38K +7.44% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.13M $569K +$34K +6.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $2.1M $551K +$13K +2.42% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $2.09M $503K -$44K -8.04% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.13M $511K -$51K -9.08% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $2.18M $535K +$19K +3.68% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.16M $538K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $547K +$109K +24.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $562K +$157K +38.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $516K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $438K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $405K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.